CD8A and neoplasm: Diamond et al. (48) showed that mice lacking IFN-α/β receptor 1 selectively in DC cannot reject methylcholanthrene-induced fibrosarcoma, a highly immunogenic tumor normally rejected by immunocompetent mice, and that CD8α DC from these mice display defective Ag cross-presentation to CD8+ T cells.